Literature DB >> 6277478

Comparison of benzo(a)pyrene metabolism in bronchus, esophagus, colon, and duodenum from the same individual.

H Autrup, R C Grafstrom, M Brugh, J F Lechner, A Haugen, B F Trump, C C Harris.   

Abstract

The metabolism of benzo(a)pyrene has been investigated in cultured normal human bronchus, colon, duodenum, and esophagus obtained from the same patient. The highest total metabolism was found in bronchus and duodenum, while the highest mean binding level was observed in the bronchus followed, in order, by the esophagus, duodenum, and transverse colon. A 30-fold interindividual variation in the binding level was found in each of the four organs studied, and a positive correlation between the binding levels in bronchus, colon, and duodenum was found. In human bronchus, a positive correlation was found between level of binding of benzo(a)pyrene to DNA and the amount of both benzo(a)pyrene 7,8-diol and the combined group of 3-hydroxybenzo(a)pyrene, benzo(a)pyrene 9,10-diol, and water-soluble metabolites. A significantly higher relative amount of benzo(a)pyrene tetrols and benzo(a)pyrene 9,10-diol was formed by human bronchus compared to the gastrointestinal tissues, while a higher level of benzo(a)pyrene phenols was formed by the latter. The relative distribution of benzo(a)pyrene-DNA adducts was similar in all four organs, the major DNA adduct being formed by trans-addition of anti-7,8-dihydroxy-9,10-epoxide-7,8,9,10-tetrahydrobenzo(a)pyrene to the 2-amino group at guanine. These results indicate that the metabolism of benzo(a)pyrene by at least four different organs is qualitatively similar but that quantitative differences exist.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6277478

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Synergistic effects of NAT2 slow and GSTM1 null genotypes on carcinogen DNA damage in the lung.

Authors:  Mi-Sun Lee; Li Su; David C Christiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-05-25       Impact factor: 4.254

2.  The immunocytochemical localisation and distribution of cytochrome P-450 in normal human hepatic and extrahepatic tissues with a monoclonal antibody to human cytochrome P-450.

Authors:  G I Murray; T S Barnes; H F Sewell; S W Ewen; W T Melvin; M D Burke
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

Review 3.  Polycyclic aromatic hydrocarbons and digestive tract cancers: a perspective.

Authors:  Deacqunita L Diggs; Ashley C Huderson; Kelly L Harris; Jeremy N Myers; Leah D Banks; Perumalla V Rekhadevi; Mohammad S Niaz; Aramandla Ramesh
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2011-10       Impact factor: 3.781

4.  Cell injury and regeneration of human epithelium in organ culture.

Authors:  J H Resau; J R Cottrell; K A Elligett; E A Hudson
Journal:  Cell Biol Toxicol       Date:  1987-12       Impact factor: 6.691

5.  Human hair follicles and cultured hair follicle keratinocytes as indicators for individual differences in carcinogen metabolism.

Authors:  M W Hukkelhoven; A C Dijkstra; A J Vermorken
Journal:  Arch Toxicol       Date:  1983-08       Impact factor: 5.153

6.  Chemical and biochemical dosimetry of exposure to genotoxic chemicals.

Authors:  G N Wogan; N J Gorelick
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.